1. Allegra JC, Lippman ME, Simon EB, Thompson EB, Barlock A, Green L, Huff KK, Do MMTC, Aitken SC, Warren R (1979) Association between steroid hormone receptor status and disease–free interval in breast cancer. Cancer Treat Rep 63: 1271–1277
2. Beatson GT (1896) On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet 2: 104–107
3. Bonadonna G, Valagusse P, Rossi A, Tancini G, Bajetta E, Marchini S, Veronesi U (1977) CMF adjuvant chemotherapy in operable breast cancer. In: Jones S, Salmon SS, Jones SE (eds.) Adjuvant therapy of cancer II. North Holland, Amsterdam, pp 83–94
4. Catt KJ, Dufau ML (1979) Peptide hormone receptors. Ann Rev Physiol 39: 529–557
5. Catt KJ, Dufau ML (1981) Hormone action: Control of target cell function by peptide, thyroid, and steroid hormones. In: Felig P, Baxter JD, Broodus AE, Frohman LA (eds) Endocrinology and metabolism. McGraw-Hill, New York, pp 61–106